Articles tagged with “risk-based-approach”

21 CFR Part 11 Compliance Guide for Small Biotech Startups

Learn 21 CFR Part 11 requirements for electronic records. This guide analyzes cost-effective FDA compliance strategies for small biotechnology startups.

40 min read

2/8/2026

21 cfr part 11 fda compliance biotech startups data integrity electronic records system validation risk-based approach electronic signatures eqms regulatory affairs

FDA's AI Guidance: 7-Step Credibility Framework Explained

Learn about the FDA's AI guidance for drug development. This article explains the 7-step credibility framework, context of use (COU), and risk-based approach.

50 min read

1/2/2026

fda guidance ai in drug development credibility framework regulatory affairs model validation context of use risk-based approach biologics regulation machine learning

GAMP 5 Categories Explained: Software, Risk & Examples

Learn the GAMP 5 software categories for computerized system validation. This guide explains each category with examples, risk levels, and how they align with the 2025 ISPE GAMP AI Guide and FDA CSA framework.

25 min read

10/16/2025

gamp 5 computer system validation gxp risk-based approach ispe software validation pharmaceutical compliance

GAMP 5: Computerized System Validation in Pharma

What is GAMP 5? A practical guide to the ISPE framework for computerized system validation: the software categories, the risk-based lifecycle, and how it maps to FDA CSA, 21 CFR Part 11, and EU Annex 11.

30 min read

5/31/2025

gamp 5 computer system validation pharmaceuticals regulatory compliance fda 21 cfr part 11 eu annex 11 ispe automated manufacturing data integrity risk-based approach